Ivana Borja

City of Hope National Medical Center

Poster(s):

• 1404 - A Phase 2 study with Tafasitamab and Zanubrutinib in newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma – TaZa CLL Study